Hélène Blons
About
Hélène Blons is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research.
According to data from OpenAlex, Hélène Blons has authored 165 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Oncology, 77 papers in Pulmonary and Respiratory Medicine and 62 papers in Cancer Research. Recurrent topics in Hélène Blons's work include Cancer Genomics and Diagnostics (54 papers), Lung Cancer Treatments and Mutations (54 papers) and Genetic factors in colorectal cancer (38 papers). Hélène Blons is often cited by papers focused on Cancer Genomics and Diagnostics (54 papers), Lung Cancer Treatments and Mutations (54 papers) and Genetic factors in colorectal cancer (38 papers). Hélène Blons collaborates with scholars based in France, Italy and Germany. Hélène Blons's co-authors include Pierre Laurent‐Puig, Audrey Didelot, Philippe Beaune, Valérie Taly, Astrid Lièvre, Karine Pallier, Marie Wislez, Daniel Brasnu, Delphine Le Corre and Jean‐François Emile and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Hélène Blons
157 papers receiving 6.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hélène Blons France | 47 | 3.3k | 2.4k | 2.3k | 2.2k | 1.2k | 165 | 6.0k | ||
| Yang Shao China | 40 | 2.7k 0.8× | 2.7k 1.1× | 2.3k 1.0× | 2.3k 1.1× | 742 0.6× | 264 | 5.8k | ||
| Colin C. Pritchard United States | 34 | 2.2k 0.7× | 2.1k 0.9× | 3.0k 1.3× | 3.2k 1.5× | 1.7k 1.4× | 133 | 6.6k | ||
| Jianming Ying China | 43 | 2.6k 0.8× | 2.1k 0.9× | 2.7k 1.2× | 1.3k 0.6× | 628 0.5× | 283 | 6.1k | ||
| Yoon‐La Choi South Korea | 51 | 3.9k 1.2× | 4.0k 1.7× | 2.8k 1.2× | 2.0k 0.9× | 833 0.7× | 288 | 8.3k | ||
| Shumei Kato United States | 38 | 4.5k 1.4× | 2.4k 1.0× | 2.2k 0.9× | 2.6k 1.2× | 1.1k 0.9× | 174 | 7.5k | ||
| Rohit Bhargava United States | 41 | 2.8k 0.9× | 1.2k 0.5× | 1.6k 0.7× | 2.4k 1.1× | 1.1k 0.9× | 171 | 5.5k | ||
| Antonio Marchetti Italy | 36 | 2.7k 0.8× | 2.9k 1.2× | 2.5k 1.1× | 2.0k 0.9× | 624 0.5× | 111 | 5.8k | ||
| Fiamma Buttitta Italy | 45 | 3.5k 1.1× | 2.9k 1.2× | 3.6k 1.6× | 2.4k 1.1× | 702 0.6× | 102 | 7.1k | ||
| Birgit Geoerger France | 43 | 2.0k 0.6× | 1.4k 0.6× | 2.6k 1.1× | 1.1k 0.5× | 700 0.6× | 209 | 6.2k | ||
| Enrique de Álava Spain | 40 | 1.9k 0.6× | 3.8k 1.6× | 2.7k 1.2× | 953 0.4× | 1.0k 0.8× | 186 | 6.9k |
Countries citing papers authored by Hélène Blons
Since
Specialization
Citations
This map shows the geographic impact of Hélène Blons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Blons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Blons more than expected).
Fields of papers citing papers by Hélène Blons
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hélène Blons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Blons. The network helps show where Hélène Blons may publish in the future.
Co-authorship network of co-authors of Hélène Blons
This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Blons. A scholar is included among the top collaborators of Hélène Blons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Blons. Hélène Blons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Elaidi, Réza, et al.. (2024). Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer. SHILAP Revista de lepidopterología. 5(6). 1435–1449.
2.
Garinet, Simon, Audrey Lupo, Thomas Denize, et al.. (2024). Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice. Pathology. 56(5). 702–709.
3.
Bottosso, Michele, Benjamin Verret, Olivier Caron, et al.. (2024). Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO Precision Oncology. 8(8). e2400139–e2400139.
4.
Didelot, Audrey, Simon Garinet, Aurélien de Reyniès, et al.. (2024). PrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up. Oncogene. 43(37). 2781–2794.
5.
Legendre, Paul, Barbara Burroni, Tali‐Anne Szwebel, et al.. (2023). EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular Characterization. International Journal of Surgical Pathology. 32(1). 150–154.
6.
Cordina‐Duverger, Emilie, Diane P. Martin, Jean Trédaniel, et al.. (2022). Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study). International Journal of Environmental Research and Public Health. 19(23). 16246–16246.
7.
Marisa, Laëtitia, Yuna Blum, Julien Taı̈eb, et al.. (2021). Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer. Clinical Cancer Research. 27(17). 4768–4780.
8.
Herbreteau, Guillaume, Fabrice Airaud, Audrey Vallée, et al.. (2021). MEM: An Algorithm for the Reliable Detection of Microsatellite Instability (MSI) on a Small NGS Panel in Colorectal Cancer. Cancers. 13(16). 4203–4203.
9.
Martin, Diane P., Sylvie Cénée, Martine Antoine, et al.. (2021). Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study). BMC Cancer. 21(1). 711–711.
10.
Bachet, Jean‐Baptiste, Hélène Blons, Pascal Hammel, et al.. (2020). Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic Adenocarcinoma. Clinical Cancer Research. 26(19). 5208–5216.
11.
Blons, Hélène, Jean‐Philippe Merlio, D. Debieuvre, et al.. (2020). PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project. Lung Cancer. 151. 69–75.
12.
Denize, Thomas, Mathilde Sibony, Hélène Blons, et al.. (2020). MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features. Modern Pathology. 34(3). 647–659.
13.
Biton, Jérôme, Audrey Mansuet‐Lupo, Nicolas Pécuchet, et al.. (2018). TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma. Clinical Cancer Research. 24(22). 5710–5723.
14.
Garlan, Fanny, Pierre Laurent‐Puig, David Sefrioui, et al.. (2017). Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study). Clinical Cancer Research. 23(18). 5416–5425.
15.
Menasché, Philippe, Valérie Vanneaux, Albert Hagège, et al.. (2017). Abstract 14798: Human Embryonic Stem Cell-derived Cardiac Progenitors for Heart Failure. One-year Results of the ESCORT Trial. Circulation.
16.
Barritault, Marc, et al.. (2017). An architecture for genomics analysis in a clinical setting using Galaxy and Docker. GigaScience. 6(11). 1–9.
17.
Pécuchet, Nicolas, Eleonora Zonta, Audrey Didelot, et al.. (2016). Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study. PLoS Medicine. 13(12). e1002199–e1002199.
18.
Pietrasz, Daniel, Nicolas Pécuchet, Elizabeth Fabre, et al.. (2016). Quel avenir pour l’ADN tumoral circulant ? État des lieux et perspectives dans les cancers colorectaux, pulmonaires non à petites cellules et pancréatiques. Bulletin du Cancer. 103(1). 55–65.
19.
Cros, Jérôme, É. Sbidian, Stéphane Hans, et al.. (2013). Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours. Annals of Oncology. 24(10). 2624–2629.
20.
Blons, Hélène, O. Laccourreye, & Pierre Laurent‐Puig. (2003). Altérations cellulaires et cancérogenèse ORL, marqueurs moléculaires et cibles thérapeutiques potentielles. Annales d Otolaryngologie et de Chirurgie Cervico-Faciale. 120(3). 152–160.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Yang Shao Breakdown of academic impact, for papers by Colin C. Pritchard Breakdown of academic impact, for papers by Jianming Ying Breakdown of academic impact, for papers by Yoon‐La Choi Breakdown of academic impact, for papers by Shumei Kato Breakdown of academic impact, for papers by Rohit Bhargava Breakdown of academic impact, for papers by Antonio Marchetti Breakdown of academic impact, for papers by Fiamma Buttitta Breakdown of academic impact, for papers by Birgit Geoerger Breakdown of academic impact, for papers by Enrique de Álava